A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Mulangu S,Dodd Le,Davey Rt,Tshiani Mbaya O,Proschan M,Mukadi D,Lusakibanza Manzo M,Nzolo D,Tshomba Oloma A,Ibanda A,Ali R,Coulibaly S,Adam C. Levine,Grais R,Diaz J,Lane Hc,Muyembe Tamfum Jj,Sivahera B,Camara M,Kojan R,Walker R,Dighero-Kemp B,Cao H,Mukumbayi P,Mbala-Kingebeni P,Ahuka S,Albert S,Bonnett T,Ian Crozier,Duvenhage M,Proffitt C,Teitelbaum M,Moench T,Aboulhab J,Barrett K,Cahill K,Cone K,Eckes R,Hensley L,Herpin B,Higgs E,Ledgerwood J,Pierson J,Smolskis M,Sow Y,Tierney J,Sivapalasingam S,Holman W,Gettinger N,Vallée D,Nordwall J

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

2019

Abstract Background Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the ...

Keywords:

Diabetes mellitus
Surgery
Disease
MEDLINE
Ebola virus
Randomized controlled trial
Intensive care medicine
Medicine
Young adult
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

756

Citations